Eva K Kempers (Eva Kempers)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Venous Thromboembolism

Systemic Lupus Erythematosus

Dna Methylation

Disease Activity

Top Venues

Rheumatology advances in practice

Scientific reports

Haemophilia : the official journal of the World Federation of Hemophilia

This page only lists publications with an associated author ORCID identifier.

Publications

Eva K Kempers, Qingui Chen, Chantal Visser, Eric C M van Gorp, Frederikus Albertus Klok, Suzanne C Cannegieter, Marieke J H A Kruip
Changes in incidence of hospitalization for cardiovascular diseases during the COVID-19 pandemic in The Netherlands in 2020. Scientific reports 13 (1) (2023)
Ferdows Atiq, Jessica M Heijdra, Fleur Snijders, Johan Boender, Eva K Kempers, Waander L van Heerde, Dominique P M S M Maas, Sandy Krouwel, Saskia E M Schols, Joke de Meris, Saskia E M Schols, Karin P M van Galen, Johanna van der Bom, Marjon H Cnossen, Karina Meijer, Karin C J Fijnvandraat, Jeroen Eikenboom, Frank W G Leebeek
Desmopressin response depends on the presence and type of genetic variants in patients with type 1 and type 2 von Willebrand disease. Blood advances 6 (18) (2022)
Eva K Kempers, Calvin B van Kwawegen, Joke de Meris, Saskia E M Schols, Karin P M van Galen, Karina Meijer, Marjon H Cnossen, Johanna G van der Bom, Karin Fijnvandraat, Jeroen Eikenboom, Ferdows Atiq, Frank W G Leebeek, null null
Social participation is reduced in type 3 Von Willebrand disease patients and in patients with a severe bleeding phenotype. Haemophilia : the official journal of the World Federation of Hemophilia 28 (2) (2021)
Eva K Kempers, Virgil A S H Dalm, Marie Josee E van Rijn, Annemarie G M G J Mulders, Frank W G Leebeek, Moniek P M de Maat, Arend Jan Gerard Jansen
Indication and outcome of lupus anticoagulant and antiphospholipid antibodies testing in routine clinical practice. Rheumatology advances in practice 5 (3) (2021)